12-69571423-G-A

Variant summary

Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2

The NM_001278356.2(FRS2):​c.401G>A​(p.Arg134Gln) variant causes a missense change. The variant allele was found at a frequency of 0.0000161 in 1,611,698 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: 𝑓 0.000046 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000013 ( 0 hom. )

Consequence

FRS2
NM_001278356.2 missense

Scores

4
15

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 5.43
Variant links:
Genes affected
FRS2 (HGNC:16971): (fibroblast growth factor receptor substrate 2) Enables fibroblast growth factor receptor binding activity and neurotrophin TRKA receptor binding activity. Involved in negative regulation of cardiac muscle cell differentiation. Acts upstream of or within fibroblast growth factor receptor signaling pathway. Located in adherens junction. Biomarker of renal cell carcinoma. [provided by Alliance of Genome Resources, Apr 2022]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -8 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.06089574).
BS2
High AC in GnomAd4 at 7 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
FRS2NM_001278356.2 linkuse as main transcriptc.401G>A p.Arg134Gln missense_variant 7/9 ENST00000549921.6 NP_001265285.1

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
FRS2ENST00000549921.6 linkuse as main transcriptc.401G>A p.Arg134Gln missense_variant 7/91 NM_001278356.2 ENSP00000450048 P1
FRS2ENST00000550389.5 linkuse as main transcriptc.401G>A p.Arg134Gln missense_variant 5/71 ENSP00000447241 P1
FRS2ENST00000397997.6 linkuse as main transcriptc.401G>A p.Arg134Gln missense_variant 5/75 ENSP00000381083 P1
FRS2ENST00000551325.1 linkuse as main transcriptc.401G>A p.Arg134Gln missense_variant 4/52 ENSP00000449432

Frequencies

GnomAD3 genomes
AF:
0.0000460
AC:
7
AN:
152060
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0000242
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.000964
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000147
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.0000604
AC:
15
AN:
248256
Hom.:
0
AF XY:
0.0000445
AC XY:
6
AN XY:
134696
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.0000292
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.000724
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00000884
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000130
AC:
19
AN:
1459638
Hom.:
0
Cov.:
29
AF XY:
0.0000110
AC XY:
8
AN XY:
726192
show subpopulations
Gnomad4 AFR exome
AF:
0.00
Gnomad4 AMR exome
AF:
0.0000673
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.000328
Gnomad4 SAS exome
AF:
0.0000116
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.00000180
Gnomad4 OTH exome
AF:
0.00
GnomAD4 genome
AF:
0.0000460
AC:
7
AN:
152060
Hom.:
0
Cov.:
32
AF XY:
0.0000269
AC XY:
2
AN XY:
74264
show subpopulations
Gnomad4 AFR
AF:
0.0000242
Gnomad4 AMR
AF:
0.00
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.000964
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.0000147
Gnomad4 OTH
AF:
0.00
Bravo
AF:
0.0000529
ExAC
AF:
0.0000414
AC:
5

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsJun 05, 2023The c.401G>A (p.R134Q) alteration is located in exon 8 (coding exon 3) of the FRS2 gene. This alteration results from a G to A substitution at nucleotide position 401, causing the arginine (R) at amino acid position 134 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.11
BayesDel_addAF
Benign
-0.31
T
BayesDel_noAF
Benign
-0.31
CADD
Uncertain
23
DANN
Benign
0.45
DEOGEN2
Benign
0.27
T;T;T;T
Eigen
Benign
-0.061
Eigen_PC
Benign
0.19
FATHMM_MKL
Uncertain
0.90
D
LIST_S2
Uncertain
0.91
.;.;D;D
M_CAP
Benign
0.032
D
MetaRNN
Benign
0.061
T;T;T;T
MetaSVM
Benign
-0.67
T
MutationAssessor
Benign
-0.14
N;N;N;.
MutationTaster
Benign
1.0
D;D;D;D
PrimateAI
Uncertain
0.58
T
PROVEAN
Benign
1.2
N;N;N;N
REVEL
Uncertain
0.45
Sift
Benign
1.0
T;T;T;T
Sift4G
Benign
0.89
T;T;T;T
Polyphen
0.023
B;B;B;.
Vest4
0.17
MutPred
0.23
Gain of catalytic residue at T137 (P = 0.0264);Gain of catalytic residue at T137 (P = 0.0264);Gain of catalytic residue at T137 (P = 0.0264);Gain of catalytic residue at T137 (P = 0.0264);
MVP
0.61
ClinPred
0.079
T
GERP RS
5.6
Varity_R
0.11
gMVP
0.31

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs770664718; hg19: chr12-69965203; COSMIC: COSV54726952; COSMIC: COSV54726952; API